127 related articles for article (PubMed ID: 18194937)
1. Plasma glucagon levels suppressed by a glucose load in a man with incidental pancreatic glucagonoma.
Mai VQ; Jones RC; Dickert JM; Clyde PW; Shakir KM
Endocr Pract; 2007; 13(7):780-4. PubMed ID: 18194937
[TBL] [Abstract][Full Text] [Related]
2. Necrolytic migratory erythema: a cutaneous clue to glucagonoma syndrome.
Remes-Troche JM; García-de-Acevedo B; Zuñiga-Varga J; Avila-Funes A; Orozco-Topete R
J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):591-5. PubMed ID: 15324403
[TBL] [Abstract][Full Text] [Related]
3. Glucagonoma syndrome and necrolytic migratory erythema.
Lobo I; Carvalho A; Amaral C; Machado S; Carvalho R
Int J Dermatol; 2010 Jan; 49(1):24-9. PubMed ID: 20465606
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro effects of somatostatin and insulin on glucagon release in a human glucagonoma.
Waeber G; Gomez F; Chaubert P; Temler E; Chapuis G; Boulat O; Nicod P; Haefliger JA
Clin Endocrinol (Oxf); 1997 May; 46(5):637-42. PubMed ID: 9231061
[TBL] [Abstract][Full Text] [Related]
5. An unusual case of subclinical diffuse glucagonoma coexisting with two nodules in the pancreas: characteristic features on computed tomography.
Azemoto N; Kumagi T; Yokota T; Kuroda T; Koizumi M; Yamanishi H; Soga Y; Furukawa S; Abe M; Ikeda Y; Hiasa Y; Matsuura B; Watanabe J; Kushihata F; Onji M
Clin Res Hepatol Gastroenterol; 2012 Jun; 36(3):e43-7. PubMed ID: 22239827
[TBL] [Abstract][Full Text] [Related]
6. Arterial stimulation and venous sampling for glucagonomas of the pancreas.
Eguchi H; Tanemura M; Marubashi S; Kobayashi S; Wada H; Okita K; Iwahashi H; Imagawa A; Shimomura I; Osuga K; Umeshita K; Wakasa K; Mori M; Doki Y; Nagano H
Hepatogastroenterology; 2012; 59(113):276-9. PubMed ID: 21940356
[TBL] [Abstract][Full Text] [Related]
7. Spleen-preserving distal pancreatectomy and lymphadenectomy for glucagonoma syndrome: A case report.
Cao X; Wang X; Lu Y; Zhao B; Shi J; Guan Q; Zhang X
Medicine (Baltimore); 2019 Sep; 98(38):e17037. PubMed ID: 31567941
[TBL] [Abstract][Full Text] [Related]
8. Cystic glucagonoma with loss of heterozygosity on chromosome 11 in multiple endocrine neoplasia type 1.
Sarui H; Yoshimoto K; Okumura S; Kamura M; Takuno H; Ishizuka T; Takao H; Shimokawa K; Itakura M; Saji S; Yasuda K
Clin Endocrinol (Oxf); 1997 Apr; 46(4):511-6. PubMed ID: 9196616
[TBL] [Abstract][Full Text] [Related]
9. The metabolic effects of chronic hyperglucagonaemia.
Nankervis A; Proietto J; Ng KW; Alford FP; Larkins R
Clin Endocrinol (Oxf); 1981 Oct; 15(4):325-33. PubMed ID: 6274544
[TBL] [Abstract][Full Text] [Related]
10. Metastatic glucagonoma: treatment with liver transplantation.
Radny P; Eigentler TK; Soennichsen K; Overkamp D; Raab HR; Viebahn R; Mueller-Horvart C; Sotlar K; Rassner G
J Am Acad Dermatol; 2006 Feb; 54(2):344-7. PubMed ID: 16443073
[TBL] [Abstract][Full Text] [Related]
11. Clinical and metabolic aspects of glucagonoma.
Leichter SB
Medicine (Baltimore); 1980 Mar; 59(2):100-13. PubMed ID: 6987481
[TBL] [Abstract][Full Text] [Related]
12. Rare presentation of endocrine pancreatic tumor: a case of diffuse glucagonoma without metastasis and necrolytic migratory erythema.
Chen HW; Chen HW; Su DH; Shun CT; Liu KL
J Formos Med Assoc; 2005 May; 104(5):363-6. PubMed ID: 15959605
[TBL] [Abstract][Full Text] [Related]
13. Cystic glucagonoma: A rare variant of an uncommon neuroendocrine pancreas tumor.
Brown K; Kristopaitis T; Yong S; Chejfec G; Pickleman J
J Gastrointest Surg; 1998; 2(6):533-6. PubMed ID: 10457311
[TBL] [Abstract][Full Text] [Related]
14. Glucagonoma syndrome.
Hashizume T; Kiryu H; Noda K; Kano T; Nakano R
J Am Acad Dermatol; 1988 Aug; 19(2 Pt 2):377-83. PubMed ID: 2842381
[TBL] [Abstract][Full Text] [Related]
15. Secretory response and immunochemical heterogeneity of glucagon in plasma and tumor extracts of a patient with glucagonoma.
Torre L; Vazquez JA; Blázquez E
Horm Res; 1986; 23(3):159-66. PubMed ID: 3005153
[TBL] [Abstract][Full Text] [Related]
16. Early detection of pancreatic glucagonoma.
Haga Y; Yanagi H; Urata J; Inada M; Shimada S; Nitahata N; Tanimura M
Am J Gastroenterol; 1995 Dec; 90(12):2216-23. PubMed ID: 8540521
[TBL] [Abstract][Full Text] [Related]
17. [Necrolytic migratory erythema revealing glucagonoma without diabetes].
Marty C; Bennet A; Bayle P; Danjoux M; Lalande T; Marguery MC; Bazex J
Ann Med Interne (Paris); 2003 Dec; 154(8):552-6. PubMed ID: 15037834
[TBL] [Abstract][Full Text] [Related]
18. Glucagonoma: anaesthetic management.
Gin VC; Zacharias M
Anaesth Intensive Care; 2009 Mar; 37(2):329-30. PubMed ID: 19400510
[No Abstract] [Full Text] [Related]
19. [A case report of malignant glucagonoma with a profile of immunoreactive glucagon before and after the operation].
Ohtsuka K; Nimura Y; Takaesu H; Yokoi S; Shionoya S; Yasui K
Nihon Shokakibyo Gakkai Zasshi; 1986 Oct; 83(10):2223-6. PubMed ID: 3029475
[No Abstract] [Full Text] [Related]
20. Laparoscopic resection for nonfunctioning small glucagon-producing tumor: report of a case and review of the literature.
Yada K; Hirano S; Himeno Y; Shibata K; Matsumoto T; Aramaki M; Kawano K; Kitano S
J Hepatobiliary Pancreat Surg; 2003; 10(5):382-5. PubMed ID: 14598140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]